Cargando…

The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups

BACKGROUND: Despite the devastating impact of anxiety disorders (ADs) worldwide, long-lasting debates on causes and remedies have not solved the clinician’s puzzle: who should be treated and how? Psychiatric classifications conceptualize ADs as distinct entities, with strong support from neuroscienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerez, Montserrat, Suárez, Enrique, Serrano, Carlos, Castanedo, Lauro, Tello, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723020/
https://www.ncbi.nlm.nih.gov/pubmed/26848265
http://dx.doi.org/10.2147/NDT.S89651
_version_ 1782411442967805952
author Gerez, Montserrat
Suárez, Enrique
Serrano, Carlos
Castanedo, Lauro
Tello, Armando
author_facet Gerez, Montserrat
Suárez, Enrique
Serrano, Carlos
Castanedo, Lauro
Tello, Armando
author_sort Gerez, Montserrat
collection PubMed
description BACKGROUND: Despite the devastating impact of anxiety disorders (ADs) worldwide, long-lasting debates on causes and remedies have not solved the clinician’s puzzle: who should be treated and how? Psychiatric classifications conceptualize ADs as distinct entities, with strong support from neuroscience fields. Yet, comorbidity and pharmacological response suggest a single “serotonin dysfunction” dimension. Whether AD is one or several disorders goes beyond academic quarrels, and the distinction has therapeutic relevance. Addressing the underlying dysfunctions should improve treatment response. By its own nature, neurophysiology can be the best tool to address dysfunctional processes. PURPOSE: To search for neurophysiological dysfunctions and differences among panic disorder (PD), agoraphobia-social-specific phobia, obsessive–compulsive disorder (OCD) and generalized anxiety disorder. METHODS: A sample population of 192 unmedicated patients and 30 aged-matched controls partook in this study. Hypothesis-related neurophysiological variables were combined into ten independent factors: 1) dysrhythmic patterns, 2) delta, 3) theta, 4) alpha, 5) beta (whole-head absolute power z-scores), 6) event-related potential (ERP) combined latency, 7) ERP combined amplitude (z-scores), 8) magnitude, 9) site, and 10) site of hyperactive networks. Combining single variables into representative factors was necessary because, as in all real-life phenomena, the complexity of interactive processes cannot be addressed through single variables and the multiplicity of potentially implicated variables would demand an extremely large sample size for statistical analysis. RESULTS: The nonparametric analysis correctly classified 81% of the sample. Dysrhythmic patterns, decreased delta, and increased beta differentiated AD from controls. Shorter ERP latencies were found in several individual patients, mostly from the OCD group. Hyperactivities were found at the right frontorbital-striatal network in OCD and at the panic circuit in PD. CONCLUSIONS: Our findings support diffuse cortical instability in AD in general, with individual differences in information processing deficits and regional hyperactivities in OCD and PD. Study limitations and the rationale behind the variable selection and combination strategy will be discussed before addressing the therapeutic implications of our findings.
format Online
Article
Text
id pubmed-4723020
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47230202016-02-04 The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups Gerez, Montserrat Suárez, Enrique Serrano, Carlos Castanedo, Lauro Tello, Armando Neuropsychiatr Dis Treat Original Research BACKGROUND: Despite the devastating impact of anxiety disorders (ADs) worldwide, long-lasting debates on causes and remedies have not solved the clinician’s puzzle: who should be treated and how? Psychiatric classifications conceptualize ADs as distinct entities, with strong support from neuroscience fields. Yet, comorbidity and pharmacological response suggest a single “serotonin dysfunction” dimension. Whether AD is one or several disorders goes beyond academic quarrels, and the distinction has therapeutic relevance. Addressing the underlying dysfunctions should improve treatment response. By its own nature, neurophysiology can be the best tool to address dysfunctional processes. PURPOSE: To search for neurophysiological dysfunctions and differences among panic disorder (PD), agoraphobia-social-specific phobia, obsessive–compulsive disorder (OCD) and generalized anxiety disorder. METHODS: A sample population of 192 unmedicated patients and 30 aged-matched controls partook in this study. Hypothesis-related neurophysiological variables were combined into ten independent factors: 1) dysrhythmic patterns, 2) delta, 3) theta, 4) alpha, 5) beta (whole-head absolute power z-scores), 6) event-related potential (ERP) combined latency, 7) ERP combined amplitude (z-scores), 8) magnitude, 9) site, and 10) site of hyperactive networks. Combining single variables into representative factors was necessary because, as in all real-life phenomena, the complexity of interactive processes cannot be addressed through single variables and the multiplicity of potentially implicated variables would demand an extremely large sample size for statistical analysis. RESULTS: The nonparametric analysis correctly classified 81% of the sample. Dysrhythmic patterns, decreased delta, and increased beta differentiated AD from controls. Shorter ERP latencies were found in several individual patients, mostly from the OCD group. Hyperactivities were found at the right frontorbital-striatal network in OCD and at the panic circuit in PD. CONCLUSIONS: Our findings support diffuse cortical instability in AD in general, with individual differences in information processing deficits and regional hyperactivities in OCD and PD. Study limitations and the rationale behind the variable selection and combination strategy will be discussed before addressing the therapeutic implications of our findings. Dove Medical Press 2016-01-18 /pmc/articles/PMC4723020/ /pubmed/26848265 http://dx.doi.org/10.2147/NDT.S89651 Text en © 2016 Gerez et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Gerez, Montserrat
Suárez, Enrique
Serrano, Carlos
Castanedo, Lauro
Tello, Armando
The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
title The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
title_full The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
title_fullStr The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
title_full_unstemmed The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
title_short The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
title_sort crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723020/
https://www.ncbi.nlm.nih.gov/pubmed/26848265
http://dx.doi.org/10.2147/NDT.S89651
work_keys_str_mv AT gerezmontserrat thecrossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT suarezenrique thecrossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT serranocarlos thecrossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT castanedolauro thecrossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT telloarmando thecrossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT gerezmontserrat crossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT suarezenrique crossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT serranocarlos crossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT castanedolauro crossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups
AT telloarmando crossroadsofanxietydistinctneurophysiologicalmapsfordifferentsymptomaticgroups